Comparison of the Treatment Effect Between Higher and Lower Plasma Homovanillic Acid Groups in Schizophrenic Patients.
- Author:
Woo Taek JEON
1
;
Chan Hyung KIM
;
Duk In JEON
;
Kwang Hyeon KIM
;
Sung Kil MIN
Author Information
1. Department of Psychiatry, Yonsei Universtiy College of Meidicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Schizophrenic Patients;
Therapeutic response;
Plasma HVA;
Plasma Haloperidol;
Plasma reduced haloperidol
- MeSH:
Chromatography, Liquid;
Haloperidol;
Homovanillic Acid*;
Humans;
Plasma*;
Psychopathology
- From:Korean Journal of Psychopharmacology
1997;8(1):90-100
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This study explored the differences of clinical response, plasma homovanllic acid concentration, haloperidol and reduced haloperidol concentration after 4 weeks haloperidol treatment between higher and lower baseline homovanllic acid concentration groups of schizophrenic patients. After a 2-weeks washout period, they entered the 4 week haloperidol treatment period. The psychopathology was assessed at baseline just before haloperidol trial and then at 1, 2, 4 week using Positive and Negative Syndrome Scale(PANSS). Also the measurement of plasma homovanillic acid(HVA), haloperidol(HP) and reduced haloperidol(RHP) levels were assessed with high performance liquid chromatography at the same time of PANSS assessments. There were no significant differences on the positive, negative, general symptom score of PANSS, haloperidol and reduced haloperidol levels at the end of 4-week between higher plasma HVA group(bsaeline pHVA> or =12.69ng/ml, 10 subjects) and lower plasma HVA group(bsaeline pHVA<12.69ng/ml, 9 subjects). In higher group, the treatment response mainly occured in 2 weeks after treatment, but in lower group, that occured therough 4 weeks. And in higher group, pHVA decresed constantly, but in lower group, pHVA did not changed in 4 weeks. There was significant correlation between plasma haloperidol levels and the clinical improvement(persentile improvement of PANSS positive, general symptom, total score) at the end of 4 week. But no significant correlation were found between plasma reduced haloperidol and RHP/HP ratio and clinical improvement. These results suggest that baseline HVA level is not a valuable therapeutic predictor but it is able to suggest that higher baseline pHVA group and lower group may have different pathophysiology.
